Antitrust / Competition

Hausfeld represents a class of direct purchasers of fresh and process potatoes bringing claims against potato growers, their cooperatives, processors, and packers that violated federal antitrust laws by conspiring to manipulate the price and supply of potatoes. federal antitrust laws by conspiring to manipulate the price and supply of potatoes.

Class action against drug manufacturer for anticompetitive conduct that has allowed for monopoly pricing and prevented generic competition for drugs Thalomid and Revlimid. 

British Airways and Virgin Atlantic conspired to increase the fuel surcharge they added to the price of tickets for “long haul” flights to and from the United States and the United Kingdom.

Over the last few years, competition authorities from 15 separate jurisdictions including Europe, the US, and Asia have undertaken over 30 investigations into anticompetitive conduct in the automotive parts sector. 

Settlements of nearly $32 million have been reached with defendant manufacturers of optical disc drives (drives that play CDs, DVDs or Blu-Ray discs) that are used in or with computers and other types of equipment conspired to fix prices for such drives.

Hausfeld serves as co-lead counsel for two certified classes of businesses that directly purchased bulk vitamins and were overcharged as a result of a ten year global price-fixing and market allocation cartel. The court approved eight major settlements between certain vitamin defendants and the Class Plaintiffs, including a landmark partial settlement of $1.1 billion.

Hausfeld represented direct purchasers in this antitrust class action alleging that defendants engaged in illegal tying, bundling, and exclusive dealing.

Hausfeld is among the counsel in this antitrust price-fixing class action in which plaintiffs allege that three Taiwanese manufacturers of Aftermarket Automotive Lighting Products (AALP) unlawfully conspired to fix prices in violation of the Sherman Act.

Hausfeld is Co-Lead Counsel for a putative class of direct purchaser plaintiffs in this antitrust price-fixing class action in which plaintiffs allege that manufacturers of processed tomato products unlawfully conspired to fix prices in violation of the federal Sherman Act.

Hausfeld represented a class of hospitals and medical providers in an antitrust class action alleging illegal bundling and monopolization.

Settlements with over 30 defendants for more than $1.2 billion over course of litigation concerning price-fixing of air cargo shipping on behalf of freight forwarders.

Hausfeld is one of the Co-Lead Counsel representing direct purchasers of shell eggs and processed egg products who allege that a near industry-wide price fixing conspiracy artificially raised the price of eggs over the past several years.

Hausfeld represents parties that engaged in over-the-counter foreign exchange ("FX") transactions with the world's largest banks and their affiliates and investors who entered into FX transactions through domestic exchanges. This class action lawsuit alleges that these banks colluded to fix and manipulate the prices of FX transactions.

Hausfeld has been appointed co-lead counsel for a putative class of direct purchaser plaintiffs in this antitrust class action alleging a conspiracy by airlines to fix the prices of passenger fares and/or fuel surcharges for trans-Pacific air passenger transportation services to and from the United States in violation of the federal Sherman Act.

The case alleges that the agreements that Blue Cross Blue Shield entities have reached to divide the market and not compete with each other constitutes a violation of the Sherman Act. 

Hausfeld is among the counsel for a putative class of direct purchaser plaintiffs in this antitrust price-fixing class action in which plaintiffs allege price-fixing by the leading manufacturers of: (a) color picture tubes (“CPTs”), which are cathode ray tubes (“CRTs”) used in color televisions and similar devices; (b) color display tubes (“CDTs”), which are CRTs used in color computer monitors or similar devices; and (c) electronic devices containing CPTs (such as televisions) or CDTs (such as computer monitors).

Hausfeld was appointed to be on the Executive Committee in this litigation representing direct-purchaser plaintiffs who allege that manufacturers of polyurethane foam fixed the prices.

Hausfeld filed the first antitrust class action on behalf of businesses against DirecTV and the National Football League.

Following Espar, Inc.’s admission of guilt in the Eastern District of New York on March 12, Hausfeld filed suit on behalf of a class of direct purchasers against Espar for its violations of the Sherman Act.

Hausfeld has been appointed sole interim lead counsel for the putative class of direct purchasers of packaged seafood products, against the leading U.S. manufacturers—Chicken of the Sea, StarKist and Bumble Bee.

Hausfeld has filed one of the first antitrust class action complaints in the country on behalf of domestic air passengers.

In one of the largest pending antitrust class actions in the United States, Hausfeld serves as Co-Lead Counsel for a proposed class of freight shippers who allege that the Defendants conspired to fix the price of rail freight services through coordinated fuel surcharge programs and policies.

Hausfeld represents a class of hospitals, laboratories and donor blood centers in this antitrust class action in which plaintiffs allege that defendants, the two dominant companies in the U.S. blood reagents industry...

Hausfeld is Co-Lead Counsel for a proposed class of broiler chicken growers in an antitrust action alleging that vertically-integrated poultry companies formed a nationwide conspiracy to suppress and maintain broiler chicken growers’ compensation below competitive levels.

Hausfeld, on behalf of purchasers of contact lenses subject to Unilateral Pricing Policies, filed a class action complaint against these manufacturers and ABB Optical Group, which is the self-proclaimed “largest distributor of soft contact lenses” in America.

Hausfeld serves as co-lead counsel for a class of dental practices in an antitrust class action alleging an illegal group boycott and price fixing conspiracy. 

Hausfeld was appointed co-lead counsel in this nationwide class action lawsuit against banks, insurance companies, and brokers alleging widespread price-fixing and bid rigging in the multi-billion dollar municipal derivatives industry dating back to 1992.

Hausfeld is Co-Lead Counsel in a class action lawsuit alleging a global conspiracy by some of the world’s largest banks to manipulate the London InterBank Offered Rate.

In the U.S., in In re Payment Card Interchange and Merchant Discount Antitrust Litigation, Master Docket No. 05-1720 (E.D.N.Y.), the Court approved a Class Action Settlement on December 13, 2013 among merchants, Visa, MasterCard, and other Defendants in the lawsuit.

Hausfeld served as co-lead counsel for a class of direct purchasers of endosurgical products, including trocars and clip appliers. 

Hausfeld has been appointed co-lead counsel for a putative class of direct purchaser plaintiffs of Korean Ramen Noodles. Plaintiffs allege that Defendants Nong Shim, Sam Yang, Ottogi, and Korea Yakult, and their subsidiaries conspired to fix the price of Korean Ramen in the United States and elsewhere.

Hausfeld serves as co-lead class counsel representing a proposed class of tax payers who became delinquent on their real property tax obligations, often as a result of disability and/or economic hardship...

Hausfeld was among the counsel for a putative class of direct purchaser plaintiffs in this antitrust class action in which plaintiffs alleged price-fixing by the leading manufacturers of TFT-LCD panels.

Hausfeld represents direct purchaser plaintiffs in the first antitrust case in the United States against Chinese manufacturers. The plaintiffs alleged that Chinese pharmaceutical companies Hebei Welcome Pharmaceutical Co. Ltd., Jiangsu Jiangshan Pharmaceutical Co., Ltd., JSPC America, Inc., Northeast Pharmaceutical (Group) Co. Ltd., Weisheng Pharmaceutical Co. Ltd., Shijiazhuang Pharmaceutical (USA), Inc., and China Pharmaceutical Group Ltd. conspired to fix prices and control export output of Vitamin C beginning in 2001.

Ed O’Bannon and thousands of former basketball and football players allege that the NCAA, its members, and its commercial partners violated federal antitrust law by unlawfully foreclosing former players from receiving any compensation related to the use of their images and likenesses.